Protection of insulin receptor substrate-3 from staurosporine-induced apoptosis

Biochemical and Biophysical Research Communications

Volumn 300, Issue 2, 2003, Pages 371-377

  Kaburagi, Yasushi ^a,b   Satoh, Shinobu ^c,e   Yamamoto Honda, Ritsuko ^b,d   Ito, Yuzuru ^a,e   Akanuma, Yasuo ^d   Sekihara, Hisahiko ^e   Yasuda, Kazuki ^a   Sasazuki, Takehiko ^a   Kadowaki, Takashi ^b   Yazaki, Yoshio ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^d INSTITUTE FOR ADULT DISEASES   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Apoptosis; Forkhead; Insulin; Insulin receptor; Insulin receptor substrate 1; Insulin receptor substrate 3; LY294002; Phosphoinositide 3 kinase; Protein kinase B; Staurosporine

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; HORMONE RECEPTOR STIMULATING AGENT; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; STAUROSPORINE; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; DNA BINDING PROTEIN; ENZYME INHIBITOR; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; MORPHOLINE DERIVATIVE; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; ANIMAL; CELL SURVIVAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HAMSTER; METABOLISM; PHYSIOLOGY;

CRICETINAE; CRICETULUS GRISEUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELL SURVIVAL; CHO CELLS; CHROMONES; CRICETINAE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INSULIN; MORPHOLINES; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; STAUROSPORINE; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 12144286481     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02855-3     Document Type: Article

References (30)

1. White M.F. The insulin signaling system and the IRS proteins. Diabetologia. 40:1997;S2-S17.
2. Yamauchi T., Kaburagi Y., Ueki K., Tsuji Y., Stark G.R., Kerr I.M., Tsushima T., Akanuma Y., Komuro I., Tobe K., Yazaki Y., Kadowaki T. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI 3-kinase), and concomitantly PI 3-kinase activation via JAK2 kinase. J. Biol.Chem. 273:1998;15719-15726.
3. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., White M.F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352:1991;73-77.
4. Sun X.J., Wang L.M., Zhang Y., Yenush L., Myers M.G. Jr., Glasheen E., Lane W.S., Pierce J.H., White M.F. Role of IRS-2 in insulin and cytokine signaling. Nature. 377:1995;173-177.
5. Lavan B.E., Lane W.S., Lienhard G.E. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:1997;11439-11443.
6. Lavan B.E., Fantin V.R., Chang E.T., Lane W.S., Keller S.R., Lienhard G.E. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:1997;21403-21407.
7. Tamemoto H., Kadowaki T., Tobe K., Yagi T., Sakura H., Hayakawa T., Terauchi Y., Ueki K., Kaburagi Y., Satoh S., Sekihara H., Yoshioka S., Horikoshi H., Furuta Y., Ikawa Y., Kasuga M., Yazaki Y., Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:1994;182-186.
8. Araki E., Lipes M.A., Patti M.E., Bruning J.C., Haag III B., Johnson R.S., Kahn C.R. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372:1994;186-190.
9. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M., Previs S., Zhang Y., Bernal D., Pons S., Shulman G.I., Bonner-Weir S., White M.F. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:1998;900-904.
10. Liu S.C., Wang Q., Lienhard G.E., Keller S.R. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J. Biol. Chem. 274:1999;18093-18099.
11. Fantin V.R., Wang Q., Lienhard G.E., Keller S.R. Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 278:2000;E127-E133.
12. Shepherd P.R., Withers D.J., Siddle K. Phosphoinositide-3 kinase: the key switch mechanism in insulin signaling. Biochem. J. 333:1998;471-490.
13. Ueki K., Yamamoto-Honda R., Kaburagi Y., Yamauchi T., Tobe K., Burgering B.M.T., Coffer P.J., Akanuma Y., Yazaki Y., Kadowaki T. Potential role of protein kinase B in insulin-induced glucose transport glycogen synthesis, and protein synthesis. J. Biol. Chem. 273:1998;5315-5322.
14. Yenush L., Fernandez R., Myers M.G. Jr., Grammer T.C., Sun X.J., Blenis J., Pierce J.H., Schlessinger J., White M.F. The Drosophila insulin receptor activates multiple signaling pathways but requires insulin receptor substrate proteins for DNA synthesis. Mol. Cell. Biol. 16:1996;2509-2517.
15. Yenush L., Zanella C., Uchida T., Bernal D., White M.F. The pleckstrin and phosphotyrosine binding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin. Mol. Cell. Biol. 18:1998;6784-6794.
16. Uchida T., Myers M.G. Jr., White M.F. IRS-4 mediates protein kinase B signaling during insulin stimulation without promoting apoptosis. Mol. Cell. Biol. 20:2000;126-138.
17. Ueno H., Kondo E., Yamamoto-Honda R., Tobe K., Nakamoto T., Sasaki K., Mitani K., Furusaka A., Tanaka T., Tsujimoto Y., Kadowaki T., Hirai H. Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function. Mol. Biol. Cell. 11:2000;735-746.
18. Kaburagi Y., Satoh S., Tamemoto H., Yamamoto-Honda R., Tobe K., Ueki K., Yamauchi T., Kono-Sugita E., Sekihara H., Aizawa S., Cushman S.W., Akanuma Y., Yazaki Y., Kadowaki T. Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transport and GLUT4 translocation in primary adipocytes. J. Biol. Chem. 272:1997;25839-25844.
19. Kaburagi Y., Momomura K., Yamamoto-Honda R., Tobe K., Tamori Y., Sakura H., Akanuma Y., Yazaki Y., Kadowaki T. Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. J. Biol. Chem. 268:1993;16610-16622.
20. Kaburagi Y., Satoh S., Yamamoto-Honda R., Ito T., Ueki K., Akanuma Y., Sekihara H., Kimura S., Kadowaki T. Insulin-independent and wortmannin- resistant targeting of IRS-3 to the plasma membrane via its pleckstrin homology mediates a different interaction with the insulin receptor from that of IRS-1. Diabetologia. 44:1991;992-1004.
21. Kaburagi Y., Yamamoto-Honda R., Tobe K., Ueki K., Yachi M., Akanuma Y., Stephens R.M., Kaplan D., Yazaki Y., Kadowaki T. The role of the NPXY motif in the insulin receptor in tyrosine phosphorylation of insulin receptor substrate-1 and Shc. Endocrinology. 136:1995;3437-3443.
22. Anderson M.J., Viars C.J., Czekay S., Cavenee W.K., Arden K.C. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics. 47:1998;187-199.
23. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 96:1999;857-868.
24. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:1994;4902-4911.
25. S6K is differentially inhibited by LY294002 and wortmannin Endocrinology. 142:2001;498-501.
26. Tseng Y.H., Ueki K., Kahn C.R. Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor 1 and insulin. J. Biol. Chem. 277:2002;31601-31611.
27. S.E. Curtis, M.D. Michael, B.E. Crute, S.R. Keller, G.E. Lienhard, Double knockout of IRS proteins reveals critical roles of IRS-1 and IRS-3 in the maintenance of glucose homeostasis, Diabetes 49 (Suppl. 1) (2000) A5 (abstract).
28. Anai M., Ono H., Funaki M., Fukushima Y., Inukai K., Ogihara T., Sakoda H., Onishi Y., Yazaki Y., Kikuchi M., Oka Y., Asano T. Different subcellular distribution and regulation of expression of insulin receptor substrate (IRS)-3 from those of IRS-1 and IRS-2. J. Biol. Chem. 273:1998;29686-29692.
29. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
30. Testa J.R., Bellacosa A. Akt plays a central role in tumorigenesis. Proc. Natl. Acad. Sci. USA. 98:2001;10983-10985.